FindTrial
Sign In

Study to understand the benefit of a hybrid cardiac rehabilitation program using a mobile app for heart patients

Real-World Evaluation of a Hybrid Cardiac Rehabilitation Program Using the LYFE Platform in Patients with Cardiac Illness: A Post-Marketing Observational Study - NA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/090952
Enrollment
200
Registered
2025-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Ayesha Shaikh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Eligible for CR per guidelines 2. Confirmed diagnosis of any cardiac conditions 3. Willing an able to provide consent 4.Has a smartphone with reliable internet connection

Exclusion criteria

Exclusion criteria: 1.Severe comorbidities contraindicating CR 2.MSK, Neurological or psychiatric condition impeding participation 3. Inability to perform 6MWT /comply with follow ups as per study 4.Unwillingness to provide consent 5. A part of another study

Design outcomes

Primary

MeasureTime frame
1. To asses the utilization of hybrid CR in patients with cardiac illness 2.To evaluate the effectiveness of Hybris rehab compared to in center CR programTimepoint: 1. Baseline 2. 85th day—

Secondary

MeasureTime frame
1. To measure the improvement in functional capacity- 6MWT 2.To asses the QOL - SF 36 questionnaire 3. to provide evidence supporting the intergation of hybrid CRTimepoint: 1. Baseline 2. 85TH day—

Countries

India

Contacts

Public ContactDr Ali Irani

Nanavati max superspeciality hospital

ali.irani@nanavatihospital.org02226172329

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026